In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity.

It can be used treat essential tremor, Parkinson’s disease, epilepsy, and neuropathic pain through sound waves ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

Brain implants, made from small clusters of brain cells, could help restore neural pathways damaged by Parkinson’s disease.

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

The Oklahoma Medical Research Foundation has received a $3 million grant to study Parkinson's disease, potentially leading to ...

Researchers at Karolinska Institutet have discovered new insights into brain changes in Parkinson's disease using advanced ...

Now, scientists in Korea have discovered that the Parkinson’s disease drug procyclidine can alleviate physical symptoms of ...

The Parkinson’s Foundation estimates that 15,000 people here in Wisconsin have Parkinson’s disease, and that number is only ...